We are back from the 20th International Congress on Neutron Capture Therapy (ICNCT), held in Kraków, Poland. This event brought together leading experts and professionals in the field of neutron capture therapy (NCT) to discuss the latest advancements and innovations.

During the congress, Holger Höltermann delivered a presentation titled “Linear Accelerators for BNCT: Commercially Available Linacs for Neutron Production.” The presentation provided in-depth insights into the commercial availability and advancements of linear accelerators specifically designed for neutron production in Boron Neutron Capture Therapy (BNCT).

We highlighted the critical role of linear accelerators in the efficient and precise production of neutrons, which are essential for effective BNCT treatments. The presentation showcased the technical advancements and capabilities of our linear accelerators, emphasizing their reliability, efficiency, and potential to enhance the overall effectiveness of BNCT.

We also engaged in discussions with fellow researchers, clinicians, and industry experts, exchanging valuable knowledge and exploring potential collaborations to further advance the field of BNCT. The feedback and interest we received were overwhelmingly positive, reinforcing our commitment to innovation and excellence in particle accelerator technology.

Participating in the 20th ICNCT provided us with a unique opportunity to demonstrate our expertise and contribute to the global discourse on neutron capture therapy. We are proud to be at the forefront of developing cutting-edge solutions that have the potential to revolutionize cancer treatment through BNCT.

We extend our gratitude to the organizers of the 20th ICNCT for hosting such an inspiring and informative event. We look forward to continuing our work in this vital field and contributing to the advancement of BNCT technologies.